Market Overview

Benzinga's Top Downgrades

Share:
Benzinga's Top Downgrades
Related THOR
Credit Suisse Reiterates Outperform, Raises Price Target On Thoratec On Updated LVAD Estimates
Benzinga's Volume Movers
Related LOW
Home Depot And Lowe's Companies May Be Reaping Benefits Of Lumber Liquidators Woes
Lowe's Companies: A Case Of Sell The News
Retail ETFs Hitting 52-Week Highs On Solid Q4 Earnings (Seeking Alpha)

Analysts at Goldman Sachs downgraded Thoratec (NASDAQ: THOR) from “buy” to “neutral.” The target price for Thoratec has been lowered from $42 to $37. Thoratec's shares closed at $32.60 on Friday.

Analysts at Oppenheimer downgraded Lowe's Companies (NYSE: LOW) from “outperform” to “perform.” The target price for Lowe's is set to $46. Lowe's shares closed at $42.67 on Friday.

Analysts at Keefe Bruyette & Woods downgraded Bank of America (NYSE: BAC) from “outperform” to “perform.” Bank of America's shares closed at $13.43 on Friday.

Jefferies downgraded Bed Bath & Beyond (NASDAQ: BBBY) from “buy” to “hold.” The target price for Bed Bath & Beyond has been lowered from $76 to $71. Bed Bath & Beyond's shares closed at $69.11 on Friday.

Latest Ratings for THOR

DateFirmActionFromTo
Feb 2015Canaccord GenuityMaintainsBuy
Feb 2015Credit SuisseMaintainsOutperform
Feb 2015JP MorganMaintainsNeutral

View More Analyst Ratings for THOR
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings

 

Related Articles (BBBY + BAC)

Around the Web, We're Loving...

Get Benzinga's Newsletters

Our Experts vs. S&P 500Powered by Benzinga
Marketfy Products Return S&P 500
Morning Profit Maker 42.72% 6.69%
The Option Prophet 91.14% 6.69%
SecretCaps 26.55% 6.69%
Short-Term Trend Trading 11.89% 6.69%
View the highest rated products→